effectiveness of tDCS on attention to eyes in children with autism spectrum

Not Applicable

Recruiting

Conditions: autism spectrum disorder.
Autistic disorder
F84.0

Registration Number: IRCT20211116053071N1

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 24

Inclusion Criteria

Diagnosis of high-functioning autism by a pediatric psychiatrist based on criteria DSM-V and confirmation of diagnosis using interview Kiddie-SADS
Mild disorder according to the Autism spectrum Disorders Screening Questionnaire (ASSQ)
Age range 15 -7 years
Having normal or corrected visual acuity with glasses (with the approval of an optometrist)
Lack of physical and neurological disease
Discontinue the drug 72 hours before the intervention under the supervision of a physician
Absence of metal implants in vivo

Exclusion Criteria

Suffering from neurological and neuropsychological diseases during the study
At any stage of the study that the subject was not willing to continue to cooperate, can be excluded from the study

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1- Total number eye fixation done. Timepoint: The first session before interval and the after fifth session with an interval of five days. Method of measurement: by Eye Tracker.;Number of first fixation done. Timepoint: The first session before interval and the after fifth session with an interval of five days. Method of measurement: by Eye Tracker.;Duration time of the first fixation. Timepoint: The first session before interval and the after fifth session with an interval of five days. Method of measurement: by Eye Tracker.;Duration time of the first fixation to eye. Timepoint: The first session before interval and the after fifth session with an interval of five days. Method of measurement: by Eye Tracker.

Secondary Outcome Measures